Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac death

Shock

Volumn 35, Issue 2, 2011, Pages 126-133

  Maio, Rui ^a   Sepodes, Bruno ^b   Patel, Nimesh S A ^c   Thiemermann, Christoph ^c   Mota Filipe, Helder ^b   Costa, Paulo ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cardiac death; Erythropoietin; quality of organs; transplantation

Indexed keywords

ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DELAYED GRAFT FUNCTION; DRUG EFFECT; HEART ARREST; HEART DEATH; HISTOLOGY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY GRAFT; KIDNEY INJURY; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; NEPHRITIS; NONHUMAN; SWINE;

ANIMALS; ERYTHROPOIETIN; KIDNEY; KIDNEY TRANSPLANTATION; PRESERVATION, BIOLOGICAL; SWINE; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTS;

EID: 78751629453     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181e83236     Document Type: Article

References (34)

1. Sanchez-Fructuoso AI, Marques M, Prats D, Conesa J, Calvo N, Perez-Contin MJ, Blazquez J, Fernandez C, Corral E, Del Rio F, et al.: Victims of cardiac arrest occurring outside the hospital: a source of transplantable kidneys. Ann Intern Med 145:157-164, 2006.
2. Westenfelder C, Biddle DL, Baranowski RL: Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55: 808-820, 1999.
3. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, et al.: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15:2115-2124, 2004. (Pubitemid 39031350)
4. Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, Thiemermann C: Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 66: 983-989, 2004.
5. Simon F, Scheuerle A, Calzia E, Bassi G, Oter S, Duy CN, Kick J, Bruckner UB, Radermacher P, Schelzig H: Erythropoietin during porcine aortic balloon occlusion-induced ischemia/reperfusion injury. Crit Care Med 36:2143-2150, 2008.
6. Forman CJ, Johnson DW, Nicol DL: Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU Int 99:162-165, 2007.
7. Bagul A, Hosgood SA, Kaushik M, Nicholson ML: Effects of erythropoietin on ischaemia/reperfusion injury in a controlled nonheart beating donor kidney model. Transpl Int 21:495-501, 2008.
8. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358, 1979.
9. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167, 1985.
10. Daha MR, van Kooten C: Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant 15(Suppl 6):41-43, 2000.
11. Yamamoto K, Wilson DR, Baumal R: Outer medullary circulatory defect in ischemic acute renal failure. Am J Pathol 116:253-261, 1984.
12. Nath KA, Norby SM: Reactive oxygen species and acute renal failure. Am J Med 109:665-678, 2000.
13. Kaushal GP, Singh AB, Shah SV: Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol 274:F587YF595, 1998.
14. Oberbauer R, Schwarz C, Regele HM, Hansmann C, Meyer TW, Mayer G: Regulation of renal tubular cell apoptosis and proliferation after ischemic injury to a solitary kidney. J Lab Clin Med 138:343-351, 2001.
15. Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C: Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22:63-69, 2004.
16. Vaziri ND, Zhou XJ, Liao SY: Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am J Physiol 266:F360YF366, 1994.
17. Weight SC, Bell PR, Nicholson ML: Renal ischaemia-reperfusion injury. Br J Surg 83:162-170, 1996.
18. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C: Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58:658-673, 2000.
19. Kone BC: Nitric oxide in renal health and disease. Am J Kidney Dis 30: 311-333, 1997.
20. Ling H, Gengaro PE, Edelstein CL, Martin PY, Wangsiripaisan A, Nemenoff R, Schrier RW: Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. Kidney Int 53:1642-1646, 1998.
21. Lieberthal W: Biology of ischemic and toxic renal tubular cell injury: role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens 7:289-295, 1998.
22. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C: Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 61:862-871, 2002.
23. Chatterjee PK, Kvale EO, Patel NS, Thiemermann C: GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells. Med Sci Monit 9:BR357YBR362, 2003.
24. Chatterjee PK, Patel NS, Sivarajah A, Kvale EO, Dugo L, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, et al.: GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/ reperfusion injury. Kidney Int 63:853-865, 2003.
25. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A: Unraveling peroxyni-trite formation in biological systems. Free Radic Biol Med 30:463-488, 2001.
26. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, Goligorsky MS: Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281:F948YF957, 2001.
27. Chatterjee PK, di Villa Bianca RD, Sivarajah A, McDonald MC, Cuzzocrea S, Thiemermann C: Pyrrolidine dithiocarbamate reduces renal dysfunction and injury caused by ischemia/reperfusion of the rat kidney. Eur J Pharmacol 482:271-280, 2003.
28. Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, Igarashi P: Hem-atopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 14:1188-1199, 2003.
29. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, et al.: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-242, 2004.
30. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR: Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 24:4442-4449, 2005.
31. Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK: Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). Int J Radiat Oncol Biol Phys 69:1008-1017, 2007.
32. Lambin P, Ramaekers BL, van Mastrigt GA, Van den Ende P, de Jong J, De Ruysscher DK, Pijls-Johannesma M: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database Syst Rev CD006158, 2009.
33. Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, An R, Bowers PJ, Burton P, Klausner MA, et al.: Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357:965-976, 2007.
34. Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, Sun BK, Kim YS, Kim J, Chang YS, et al.: Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17:1754-1755, 2003.